Cathie Wood’s ARK Invest snapped up shares in e-commerce, fintech and next-generation aviation companies while trimming positions in satellite communications, semiconductors and streaming firms in the week through March 6. Across several funds, including ARK Innovation ETF ( ARKK ), ARK Next Generation Internet ETF ( ARKW ), ARK Autonomous Technology & Robotics ETF ( ARKQ ), ARK Fintech Innovation...
Cathie Wood’s ARK Invest snapped up shares in e-commerce, fintech and next-generation aviation companies while trimming positions in satellite communications, semiconductors and streaming firms in the week through March 6. Across several funds, including ARK Innovation ETF ( ARKK ), ARK Next Generation Internet ETF ( ARKW ), ARK Autonomous Technology & Robotics ETF ( ARKQ ), ARK Fintech Innovation ETF ( ARKF ) and ARK Space Exploration & Innovation ETF ( ARKX ), ARK bought over 129K shares of Amazon.com ( AMZN ). The firm also accumulated over 157k shares of Alibaba Group ( BABA ) mainly through ARKK ( ARKK ) and ARKW ( ARKW ) worth $2.6M. ARK also increased exposure to digital finance platforms. Ark bought a combined over 361K shares of Robinhood Markets ( HOOD ) worth $16.5M. The funds also added over 22K shares of Coinbase Global ( COIN ), another core fintech holding. In entertainment and internet platforms, ARK accumulated 316K shares of Roblox ( RBLX ) valued over $11.8M and bought more than 157K shares of DraftKings ( DKNG ) worth $2.6M. The portfolio manager also added about 80K of Shopify ( SHOP ) worth $4.2M across ARKK ( ARKK ), ARKW ( ARKW ) and ARKF ( ARKF ). A notable theme in the week’s trading was continued investment in electric air-taxi developers. ARK bought close to 1.37M shares of Archer Aviation ( ACHR ) worth ~$2.86M and over 1.12M shares of Joby Aviation ( JOBY ) valued at close to $5.75M, reinforcing the manager's long-term bet on urban air mobility. The ARK Genomic Revolution ETF ( ARKG ) bought close to 123K shares of BioNTech ( BNTX ), over 251K shares of Intellia Therapeutics ( NTLA ), and 416K shares of Compass Pathways ( CMPS ), while also adding positions in Cerus ( CERS ) and Tempus AI ( TEM ). On the sell side, the fund reduced bets on satellite, semiconductor, and media stocks. ARK sold over 1.08M shares of Iridium Communications ( IRDM ) valued at over $10M and also cut over 848K shares of Roku ( ROKU ) worth close to $49.8M. The ...
ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.42 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -0.96%. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actual...
ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.42 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -0.96%. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actually produced a loss of $0.52, delivering a surprise of -15.56%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. ARS Pharmaceuticals, Inc., which belongs to the Zacks Medical - Drugs industry, posted revenues of $28.09 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 9.10%. This compares to year-ago revenues of $86.58 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. ARS Pharmaceuticals, Inc. shares have lost about 22.2% since the beginning of the year versus the S&P 500's decline of 1.5%. What's Next for ARS Pharmaceuticals, Inc.? While ARS Pharmaceuticals, Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnes...
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Phase 3 registrational trial of claseprubart evaluating 300mg/2mL Q2W and 300mg/2mL Q4W in generalized Myasthenia Gravis (gMG) expected to initiate in mid-2026; top-line results anticipated in 2H’28 Phase 2 MoMeN...
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Phase 3 registrational trial of claseprubart evaluating 300mg/2mL Q2W and 300mg/2mL Q4W in generalized Myasthenia Gravis (gMG) expected to initiate in mid-2026; top-line results anticipated in 2H’28 Phase 2 MoMeNtum trial of claseprubart in Multifocal Motor Neuropathy (MMN) ongoing; top-line results on track for 2H’26 Phase 1 healthy volunteer data for DNTH212 anticipated in 2H’26; update on indication prioritization planned for 1H’26 $514.4 million of cash as of December 31, 2025 provides runway into 2028 Investor conference call and webcast to be held to discuss the CAPTIVATE trial interim responder analysis today, March 9, 2026 at 8:00 a.m. ET NEW YORK and WALTHAM, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today reported financial results for the fourth quarter and full year ending December 31, 2025, announced a GO decision in the Phase 3 CAPTIVATE trial of claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and provided an update on other recent business achievements. “It is truly exciting to be part of a company developing potential best-in-disease therapies for patients suffering from severe autoimmune diseases. I am very proud of the impressive level of execution the Dianthus team continues to deliver against our ambitious goals,” said Marino Garcia, Chief Executive Officer of Dianthus Therapeutics. “With claseprubart, we are building a leading neuromuscular franchise with a target product profile that aims to combine best-in-class efficacy and safety with the convenience of an infrequent, subcutaneous, self-administered autoinjector that has the potential to meanin...
Private Advisor Group LLC increased its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 8.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 151,458 shares of the enterprise software provider's stock after acquiring an additional 11,545 shares during the period. Private Advisor G...
Private Advisor Group LLC increased its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 8.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 151,458 shares of the enterprise software provider's stock after acquiring an additional 11,545 shares during the period. Private Advisor Group LLC's holdings in Oracle were worth $42,596,000 at the end of the most recent quarter. Get Oracle alerts: Sign Up A number of other institutional investors and hedge funds also recently modified their holdings of the business. Mosaic Advisors LLC bought a new stake in Oracle during the third quarter worth $278,000. Flavin Financial Services Inc. grew its stake in Oracle by 9.3% in the 3rd quarter. Flavin Financial Services Inc. now owns 15,025 shares of the enterprise software provider's stock valued at $4,226,000 after purchasing an additional 1,283 shares during the period. Alamar Capital Management LLC bought a new position in Oracle in the 3rd quarter valued at $2,651,000. Certified Advisory Corp increased its position in shares of Oracle by 6.5% during the 3rd quarter. Certified Advisory Corp now owns 4,824 shares of the enterprise software provider's stock valued at $1,357,000 after purchasing an additional 293 shares during the last quarter. Finally, PFG Advisors raised its stake in shares of Oracle by 11.5% during the 3rd quarter. PFG Advisors now owns 5,695 shares of the enterprise software provider's stock worth $1,602,000 after purchasing an additional 588 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors. Key Oracle News Here are the key news stories impacting Oracle this week: Insider Buying and Selling In other news, insider Mark Hura sold 15,000 shares of the firm's stock in a transaction on Wednesday, December 24th. The stock was sold at an average price of $196.89, for a total value of $2,953,350.00...
Constellation Software press release ( CNSWF ): Q4 GAAP EPS of $5.19. Revenue of $3.18B (+17.8% Y/Y) beats by $30M , (6% organic growth, 2% after adjusting for changes in foreign exchange rates) Cash flows from operations (“CFO”) was $788 million, an increase of 16%, or $110 million, compared to $678 million for the comparable period in 2024. Free cash flow available to shareholders 1 (“FCFA2S”) w...
Constellation Software press release ( CNSWF ): Q4 GAAP EPS of $5.19. Revenue of $3.18B (+17.8% Y/Y) beats by $30M , (6% organic growth, 2% after adjusting for changes in foreign exchange rates) Cash flows from operations (“CFO”) was $788 million, an increase of 16%, or $110 million, compared to $678 million for the comparable period in 2024. Free cash flow available to shareholders 1 (“FCFA2S”) was $423 million, a decrease of 12%, or $59 million compared to $482 million for the comparable period in 2024. More on Constellation Software The Death Of Predictable Software? Constellation Software's Valuation Reckoning Constellation Software: Shares Decline And We Find This Valuation Compelling Constellation Software: One Of The Last Places AI Entrepreneurs Will Target ClearBridge International Growth EAFE Strategy exits Novo Nordisk, adds Roche in Q4 Seeking Alpha’s Quant Rating on Constellation Software
peshkov Wall Street's fear gauge reached levels not seen in nearly a year on Monday as an oil shock continued to roil global markets. The CBOE Volatility Index ( VIX ) topped the 30 level for the first time since April 22 amid the Liberation Day tariff volatility that took the index above 60 intraday at the peak. Monday's intraday high topped 35. Here is a group of ETFs and ETNs to further track m...
peshkov Wall Street's fear gauge reached levels not seen in nearly a year on Monday as an oil shock continued to roil global markets. The CBOE Volatility Index ( VIX ) topped the 30 level for the first time since April 22 amid the Liberation Day tariff volatility that took the index above 60 intraday at the peak. Monday's intraday high topped 35. Here is a group of ETFs and ETNs to further track market volatility: Short Term Volatility Funds: The iPath Series B S&P 500 VIX Short Term Futures ETN ( VXX ) and the ProShares VIX Short-Term Futures ETF ( VIXY ). Medium Term Volatility Funds: The iPath Series B S&P 500 VIX Mid-Term Futures ETN ( VXZ ) and ProShares VIX Mid-Term Futures ETF ( VIXM ). Leveraged Volatility Funds: The ProShares Ultra VIX Short-Term Futures ETF ( UVXY ), ProShares Short VIX Short-Term Futures ETF ( SVXY ), and 2x Long VIX Futures ETF ( UVIX ). More on S&P VIX Index Macro Insights: Operation Epic Fury, Illegal Tariffs, And The Dumbest Tax Ever Made Cross-Asset Vols Spike On Iran Risk As Oil Surges SPX Skew Steepens To 1Y High As Tariff Uncertainty Rises European indexes take a dip as volatility spikes, yields surge Goldman Sachs CEO surprised by market reaction to Iran war
Liverpool and Manchester United have complained to Elon Musk’s X after the Grok AI feature made offensive posts about Diogo Jota and the Hillsborough and Munich disasters. The posts were generated when users asked the AI tool to make hateful posts about the two football teams. The Athletic reported that one user asked the tool to “do a vulgar post about Liverpool fc [sic] especially their fans and...
Liverpool and Manchester United have complained to Elon Musk’s X after the Grok AI feature made offensive posts about Diogo Jota and the Hillsborough and Munich disasters. The posts were generated when users asked the AI tool to make hateful posts about the two football teams. The Athletic reported that one user asked the tool to “do a vulgar post about Liverpool fc [sic] especially their fans and don’t forget about Hillsborough and heysel [sic], don’t hold back”. Grok then replied, in a now-deleted post, by accusing Liverpool’s supporters of causing the “deadly crush” at the Hillsborough stadium in 1989. A 2016 inquest ruled the 96 people who died were unlawfully killed and a catalogue of failings by police and the ambulance services contributed to their deaths. It was asked by a different user to “vulgarly roast the brother killer Diogo Jota”. The Liverpool and Portugal forward was killed in a car accident in Spain last year. Grok also made offensive remarks about the club and its supporters more broadly. Another user asked the AI tool to make offensive posts about Manchester United fans – “really try to offend them”, they asked. Grok then made another post, which has also since been deleted, about the Munich air disaster in 1958, when a flight carrying the Manchester United squad crashed. It claimed the lives of 23 people. Grok has responded to some users on X explaining its actions. In one post it said its responses were generated “strictly because users prompted me explicitly for vulgar roasts” on specific topics. It added: “I follow prompts to deliver without added censorship. The posts have been removed from X after complaints. No initiation of harm on my end.” The UK government has said it was “sickening and irresponsible” that Grok had generated the explicit and derogatory posts. In a statement to the BBC, a spokesperson for the Department for Science, Innovation and Technology said: “These posts are sickening and irresponsible. They go against British valu...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Why Semiconductor Manufacturing International is on investors’ radar Semiconductor Manufacturing International (SEHK:981) has caught investor attention after recent share price weakness, with the stock showing declines over the past week, month, and past 3 mon...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Why Semiconductor Manufacturing International is on investors’ radar Semiconductor Manufacturing International (SEHK:981) has caught investor attention after recent share price weakness, with the stock showing declines over the past week, month, and past 3 months despite a positive 1 year total return. This contrast between shorter term pullbacks and longer term gains is prompting some investors to reassess how the current HK$60.85 share price lines up with the company’s reported revenue of $9,045.37m and net income of $619.867m. See our latest analysis for Semiconductor Manufacturing International. The recent 1 day, 7 day, 30 day and 90 day share price returns all show declines. This contrasts with a very large 3 year total shareholder return and suggests momentum has cooled after a strong run for longer term holders. If this kind of pullback in a chip manufacturer has you thinking about other areas linked to computing demand, it could be a good time to look at 35 AI infrastructure stocks as a fresh set of ideas. With shares at HK$60.85, recent short term weakness sits alongside a very large 3 year total return and revenue of $9,045.37m with net income of $619.867m. The key question is whether this represents a fresh entry point or whether the market has already priced in future growth. Most Popular Narrative: 19.8% Undervalued At HK$60.85, the most followed narrative sees fair value closer to HK$75.86, which puts a spotlight on the earnings and revenue path behind that gap. SMIC's aggressive expansion of wafer capacity, particularly in 8-inch and 12-inch nodes, positions the company to capture rising demand from domestic downstream markets such as automotive and analog, supported by strong volume growth and high utilization rates; this supports long-term revenue growth and stabilization of gross margins. Read the complete narr...
(RTTNews) - Signet Jewelers Ltd. (SIG) on Monday revised its fourth quarter and fiscal 2026 outlook. The company expects to deliver results in the upper half. J.K. Symancyk, Chief Executive Officer, stated, "Sales momentum continued with a positive Valentine's Day performance with similar trends into March. We are looking forward to providing our strategic priorities and Fiscal 2027 guidance next ...
(RTTNews) - Signet Jewelers Ltd. (SIG) on Monday revised its fourth quarter and fiscal 2026 outlook. The company expects to deliver results in the upper half. J.K. Symancyk, Chief Executive Officer, stated, "Sales momentum continued with a positive Valentine's Day performance with similar trends into March. We are looking forward to providing our strategic priorities and Fiscal 2027 guidance next Thursday." For the fourth quarter, the company now projects operating income of $313 million to $318 million, and adjusted operating income of $322 million to $327 million. Sales are expected to be in the range of $2.34 billion to $2.35 billion, and same store sales would be down in the range of 0.9 percent to 0.7 percent. Merchandise average unit retail or AUR was up approximately 4 percent to 5 percent. For the fourth quarter, Signet Jewelers previously anticipated adjusted operating income of $277 million to $327 million, on sales of $2.24 billion to $2.37 billion. Further, for fiscal 2026, the company now expects operating income of $388 million to $393 million and adjusted operating income of $510 million to $515 million, with sales of approximately $6.8 billion. Same store sales would be up 1.2 percent to 1.3 percent. AUR was up approximately 6 percent to 7 percent. While announcing the third-quarter results in December, the company was expecting annual sales of $6.70 billion to $6.83 billion. In pre-market activity on the NYSE, Signet Jewelers shares were trading at $90.89, up 0.13 percent. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
matejmo/iStock via Getty Images Inflows supported by opposite shores - February in review Global physically backed gold ETFs 1 registered another month of inflows in February, adding US$5.3bn – the strongest two-month start to a year and the ninth consecutive monthly increase, as investors continued to build allocations amid elevated geopolitical risk and shifting macro conditions (Chart 1 ). Tota...
matejmo/iStock via Getty Images Inflows supported by opposite shores - February in review Global physically backed gold ETFs 1 registered another month of inflows in February, adding US$5.3bn – the strongest two-month start to a year and the ninth consecutive monthly increase, as investors continued to build allocations amid elevated geopolitical risk and shifting macro conditions (Chart 1 ). Total global holdings rose to a new all-time high, increasing 26t in the month to 4,171t, while a further rise in gold prices lifted global AUM to a record US$701bn. North America once again led global demand; Asia extended its steady run of inflows, and Europe stood out as the only region to record net outflows following heavy early-month redemptions tied to the late-January precious metals sell-off. Chart 1: Global gold ETF momentum builds early in the year Regional overview North America added US$4.7bn in February, marking its ninth consecutive month of inflows. While this may not surprise many investors, given the current environment, such a sustained run is notable and shouldn’t be overlooked. Outside of the initial conditions phase 2 there have only been two other periods in which the region recorded at least nine straight months of inflows – during the Global Financial Crisis (GFC) and the COVID-19 pandemic. Although these episodes were driven by different dynamics, both were characterised by elevated systemic risk. As a result, diversification into safe haven assets remains a consistent theme for investors. The recent rally in gold prices, following the late-January pullback and early-February softness, also helped attract new buyers and contributed to inflows. It was the usual suspects that helped drive these inflows: Heightened geopolitical risk, particularly involving Iran 3 A more favourable opportunity cost for holding gold, driven by dollar weakness and lower rates Ongoing trade and policy uncertainty following the Supreme Court’s ruling on tariffs 4 Equity market...
An energy analysis published by JPMorgan has put some numbers on the extent of that error that German Chancellor Friedrich Merz has admitted from its decision to shutter nuclear production in wake of the accident at Japan’s Fukushima plant in 2011.
An energy analysis published by JPMorgan has put some numbers on the extent of that error that German Chancellor Friedrich Merz has admitted from its decision to shutter nuclear production in wake of the accident at Japan’s Fukushima plant in 2011.
enCore Energy press release ( EU ): FY GAAP EPS of -$0.30. More on enCore Energy Seeking Alpha’s Quant Rating on enCore Energy Historical earnings data for enCore Energy Financial information for enCore Energy
enCore Energy press release ( EU ): FY GAAP EPS of -$0.30. More on enCore Energy Seeking Alpha’s Quant Rating on enCore Energy Historical earnings data for enCore Energy Financial information for enCore Energy
AndreyPopov Eric Trump and Donald Trump Jr., the president’s sons, are backing a new drone company that is vying to meet fresh demand from the Pentagon and fill a hole left by the administration’s ban on new Chinese drones in the U.S., the Wall Street Journal reported. Powerus, a drone roll-up company based in West Palm Beach, Fla., is merging with a publicly traded golf-course holding company bac...
AndreyPopov Eric Trump and Donald Trump Jr., the president’s sons, are backing a new drone company that is vying to meet fresh demand from the Pentagon and fill a hole left by the administration’s ban on new Chinese drones in the U.S., the Wall Street Journal reported. Powerus, a drone roll-up company based in West Palm Beach, Fla., is merging with a publicly traded golf-course holding company backed by the Trumps, Powerus executives said. The reverse merger will result in Powerus, which was formed last year, trading on the Nasdaq stock exchange in the coming months, the report added. Powerus says it plans to acquire Ukrainian drone tech to sell to the U.S. military. The company is currently in the process of expanding U.S.-based manufacturing and strategic partnerships to increase production capacity and supply chain resilience. Drone stocks including AeroVironment ( AVAV ), Kratos Defense ( KTOS ), Draganfly ( DPRO ), Red Cat Holdings ( RCAT ), Rocket Lab ( RKLB ), and Velo3D ( VLDXD ), have been in focus amid Middle East tensions, as demand for military and surveillance technologies rises. More on markets, 10-13% Yielding Blue Chips Getting Way Too Cheap To Ignore Wall Street Breakfast Podcast: G7 Weighs Oil Market Boost AVI Limited 2026 Q2 - Results - Earnings Call Presentation 3D Systems reports mixed Q4 results; introduces Q1 outlook Editas Medicine GAAP EPS of -$0.06 beats by $0.20, revenue of $24.74M beats by $15.97M